top of page


News


Alpha Tau to Participate in May Investor Conferences
JERUSALEM, May 1, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative...
May 1, 2024


Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
JERUSALEM, March 25, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Mar 25, 2024


Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update
- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response...
Mar 8, 2024


Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
JERUSALEM, February 26, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Feb 26, 2024


Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the...
Dec 20, 2023


Alpha Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Nov 29, 2023


Alpha DaRT Advanced Pancreatic Cancer Trial : Highly Promising Interim Results
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no...
Nov 28, 2023


ATM submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT for Recurrent Head & Neck Cancer
Jerusalem, November 20, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative...
Nov 20, 2023


Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- Treated the first patient with advanced inoperable pancreatic cancer at Hadassah Medical Center in Israel in September, alongside...
Nov 19, 2023


Alpha Tau to Participate in November Investor Conferences
JERUSALEM, November 1, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Nov 1, 2023
bottom of page